Home|Journals Follow on Twitter| Subscribe to List

Directory for Medical Articles
 

Open Access

Original Article

J App Pharm Sci. 2017; 7(3): 180-187


Therapeutic effects of aqueous, methanol and ethanol extracts of Egyptian Artemisia herba-alba in STZ-induced diabetic neuropathy in rats

Salma A. El-Marasy; Eman R. Zaki; Heba M.I. Abdallah; Mahmoud S. Arbid.

Abstract
Diabetes mellitus is a common cause of peripheral neuropathy and patients suffer from chronic peripheral pain. Artemisia herba alba (Ah) is a prevalent plant with extensive traditional uses. This study aimed to investigate the therapeutic effects of Ah in STZ-model of diabetic peripheral neuropathy. After induction of diabetes, rats were treated with aqueous, 100% methanol and 70% ethanol extracts of Ah at doses of 50 and 100mg/kg for each extract; respectively. Behavioral tests (Tail flick, hot plate and locomotor activity) were performed on animals. Blood glucose was measured in serum and oxidative stress biomarkers (GSH, MDA, CAT and GST) were assessed in isolated sciatic nerve. RESULTS: Treatment with aqueous, methanol and ethanol extracts of Ah decreased blood glucose level, increased tail withdrawal latency and retention time (in tail flick and hot plate tests; respectively) and increased diabetic rats movements in the activity cage. The extracts also inhibited oxidative stress status by decreasing lipid peroxidation and enhancing GSH and antioxidant enzymes; CAT and GST. Therefore, treatment with Ah ameliorated painful diabetic neuropathy in STZ rats which was evident by improved nociceptive latency and locomotor activity. The therapeutic effect of the plant could be mediated by antioxidant mechanisms.

Key words: Artemisia herba-alba; diabetes; neuropathy; STZ;oxidative stress



Share this Article


Advertisement
Journal of Environmental and Occupational Science

SUBMIT YOUR ARTICLE NOW


ScopeMed.com
ScopeMed Home
Follow ScopeMed on Twitter
BiblioCAM
Author Tools
eJPort Journal Hosting
About ScopeMed
License Information
Terms & Conditions
Privacy Policy
Suggest a Journal
Publisher Login
Contact Us

The articles in Scopemed are open access articles licensed under the terms of the Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License (https://creativecommons.org/licenses/by-nc-sa/4.0/) which permits unrestricted, non-commercial use, distribution and reproduction in any medium, provided the work is properly cited.
ScopeMed is a Database Service for Scientific Publications. Copyright ScopeMed Information Services.
Scopemed Buttons